EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS052-38808 
Organism
Homo sapiens 
Tissue/cell
Fibroblast_foreskin 
Coordinate
chr9:94908300-94910430 
TF binding sites/motifs
Number: 19             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr9:94909571-94909589TCCTCCTTCCTTCTCTCC-6.25
EWSR1-FLI1MA0149.1chr9:94909559-94909577CCTGCCTTCCCTTCCTCC-6.39
EWSR1-FLI1MA0149.1chr9:94908971-94908989GGAAGGAGGGAAGGGGAG+6.4
EWSR1-FLI1MA0149.1chr9:94909563-94909581CCTTCCCTTCCTCCTTCC-6.75
EWSR1-FLI1MA0149.1chr9:94908967-94908985GAAGGGAAGGAGGGAAGG+6.84
EWSR1-FLI1MA0149.1chr9:94909575-94909593CCTTCCTTCTCTCCCTCC-6.94
MYCNMA0104.4chr9:94910293-94910305GCCCACGTGGCC+6.27
MYCNMA0104.4chr9:94910293-94910305GCCCACGTGGCC-6.27
Myod1MA0499.1chr9:94909799-94909812AGGGGCAGCTGCT-6.18
TP53MA0106.3chr9:94909728-94909746GACTTGCCTGGGCTTGTT+6.65
TP53MA0106.3chr9:94909728-94909746GACTTGCCTGGGCTTGTT-7
ZNF263MA0528.1chr9:94909630-94909651TCCTTCCCCCTTCCTTCCTTT-6.02
ZNF263MA0528.1chr9:94908963-94908984GAGGGAAGGGAAGGAGGGAAG+6.18
ZNF263MA0528.1chr9:94909556-94909577TCCCCTGCCTTCCCTTCCTCC-6.56
ZNF263MA0528.1chr9:94909571-94909592TCCTCCTTCCTTCTCTCCCTC-6.58
ZNF263MA0528.1chr9:94909534-94909555TCCCCCCCTCCTTCCTGCCCT-6.59
ZNF263MA0528.1chr9:94909563-94909584CCTTCCCTTCCTCCTTCCTTC-6.86
ZNF263MA0528.1chr9:94909575-94909596CCTTCCTTCTCTCCCTCCCTC-7.94
ZNF263MA0528.1chr9:94909579-94909600CCTTCTCTCCCTCCCTCCTTT-7
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_02741chr9:94908477-94910639Astrocytes
SE_37838chr9:94907362-94917076HSMMtube
SE_39324chr9:94905779-94910548IMR90
SE_46370chr9:94907846-94911556Osteoblasts
SE_56505chr9:94907669-94911466u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr99490893294910146
Number: 1             
IDChromosomeStartEnd
GH09I092145chr99490790894911436
Enhancer Sequence
TGGGAGGGAG GGAAGCAGGC CTATTCTATG AAAGGTGTAG GATAGGTGTG TGTGTAGTTG 60
CGGGCTGTGA GAGGTGCAAG AAGCTGCGAA GAAGATGGAA TGAGCTCTGC TGGGAACCCA 120
GAGTAATTTT AGGGTTTTTT TTTTTTGTTT TTTTTTTTTT TAGAATACAG TCTGAAAAAC 180
CAGGGAGGGG AGGGGAGCAC CTGATGGAAG ACGCCAGCGT GCTCCCTTAC ATGGTCTAGA 240
CGGGCCCCTG CAGGGGCTAC AGATGAGGAG GCAGAGAAAC AGGCGGCCTT AACAGGGGAG 300
AGCCAGCCTT GGAGAGGATG TATTGTGAAT TGGGGGTGGG GGTGCCAACG TGCCAGGTCT 360
CATTTCTCAC TTCCAAGGCC ACCCTTCCCT GGCCCAGTCT TAGTCGCCCT TTCTAATAGA 420
TTCTAAGAGT TTGACTCCTC CTTCCGGAAA CTTGGGGTTT GTGAGTTCTA ATCTTCAGTC 480
TCTCAGTTGC TATGAGACCC TGTGCAAGTC CCAAAACTTC CCTGGACCTC AATGTCCAGA 540
GAAGCCATGT TTTGGATGAA AAACTAGAAA GTGGGAGAGG CAGGGCGCAA TCCTCTTTGA 600
GTCTCCTGCT CCTGGTGTGG GACAGAGAAA GCTCCCAGGG AGAGCTGCTC AGCTGCAGGC 660
AGTGAGGGAA GGGAAGGAGG GAAGGGGAGG ACCCAGGCAG CATCCAGACC AGGGTGGGGA 720
AGAGAACTTA TTCTTAAGCA ACTTATTCTT AAGCAGCTTC CTGTTCTCTT AGCCTTGAAC 780
TTGAAGCCAG GAATAGGGAC AGGGATAGAA GAGCCAAGGC TTGGAGCCGC TGGCCTATGC 840
AGATGCACTT GCTTGTCCAG CAACAGTTGG ACAGGGCCTG GCCTGGGCAA TGTGCTCCGG 900
GGTGCATGGA AAATGTGGTC ATTCTTTGTC CGGGGGATTC TTCTTATTCC CTCCCATTTC 960
TCTTTACAGA GAATTTTACA CTTCCTTGCA GACACTGAAT TATTGTGTTA AATTATTATA 1020
ACTTAATAGC TTGTGAAATA TACAAACAAC AAGATTATGC CGACATGGCT GTTAGAAGAC 1080
AAGACAAATT AGCAGACTCA TGCTCATTTC TGTCATTGAA CAATTCGTCT CATTCCTTCC 1140
TCAAGGCGCT GCCGTTTTCC TGCTCTCCGT CCGTGGGGGT GTTTGTTTAC ACATCTCTCG 1200
CAAGAAAAGC GCTTCTCTCT GGCTTCCCTC TGCCTCCCCC CCTCCTTCCT GCCCTCTCCC 1260
CTGCCTTCCC TTCCTCCTTC CTTCTCTCCC TCCCTCCTTT TCTCCCCGTT CCTTTCTTCC 1320
CTTCTCTCTG TCCTTCCCCC TTCCTTCCTT TACTGATGTA ACAACCTTGG TGTGCCGTGG 1380
CTAAGCCACA CTCCACCCCT GACCTGCGGG GGATGAGTCA AACGGTCAGA CTTGCCTGGG 1440
CTTGTTCCAC GCTCCCCTGG CTAGACAGGC GTCTACACAT TCTCAGTTAG GGGCTGGACA 1500
GGGGCAGCTG CTAGACAGGT CCTATTCTGG GCCTCTCTGA GAAAAAGTGT CCCTGAAAAG 1560
AAAGGGAGCT CCCACTTCCA TGGACCCTTA GCCATGCCAA GGGGCAGTAC CGGCTTTCTG 1620
CTGGTGCTGA TGAGCTGTGG TGTGAACTCA CGAAGGTCAG CTGATTCACG GGCCCTGGAT 1680
CTCTGCTCTC CTTCCGCTAA GTGGGACTCG GGCCAGCCTG CCATGAAGGA GGTAGCTGCT 1740
GCAGCTTTCA GGAAGGAACA CCAGGTGTCA ACCCCACCGG GTGGCCAACC CCACCTGGCT 1800
AGGACCCAGT CCCTGGTGGC TGCTCTCCCG AGAGGCGGGC AGGGCTGGGG CTAGGGGCTG 1860
TCCAGGAGTG TTCTGGACTG TCCCTTCGCC ACAATTCCCA CAGGCTGCTC AGGACCGAGG 1920
CTGAGACGGG CGACCAGGAC GGGATTGTAT GGCTGCAGGA GGCTACACAG TCCCAGGAGG 1980
CTGCTTCTAA GAGGCCCACG TGGCCTGCAT GGGGATGCGC CTGGCTGTCC AGCATGTGGT 2040
CATTTGAATT GTACATGTTT CACTGGGATG CCTACAGAAA AGTAGACAGA AGATGTGGAA 2100
AAAGTTTTTG AAATGTTGCA AACTTAGCTA 2130